Transdermal Granisetron: A Guide to Its Use in Preventing Nausea and Vomiting Induced by Chemotherapy

被引：14

作者：

Keating, Gillian M. ^{[1
]}

Duggan, Sean T. ^{[1
]}

Curran, Monique P. ^{[1
]}

机构：

[1] Adis, Auckland 0754, New Zealand

来源：

CNS DRUGS | 2012年 / 26卷 / 09期

关键词：

THERAPEUTIC USE;

D O I：

10.2165/11209440-000000000-00000

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

100204 [神经病学];

摘要：

Transdermal granisetron (Sancuso (R)) is effective in the prevention of nausea and vomiting in patients with cancer who are receiving moderately or highly emetogenic chemotherapy for 3-5 days. Transdermal granisetron is noninferior to oral granisetron in this indication, and is generally well tolerated in this indication. Thus, transdermal granisetron provides a convenient option for the prevention of chemotherapy-induced nausea and vomiting, with the potential to improve patient compliance.

引用

页码：787 / 790

页数：4

共 12 条

[1]

[Anonymous], 2012, SANC 3 1 MG 24 HOURS

[2]

[Anonymous], 2021, BREAST CANC SCREEN D

[3]

[Anonymous], SANC GRAN TRANSD SYS

[4]

Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study [J].